GMO SGM Major Markets Fund
GSMFX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 40 Rowes Wharf Boston MA United States of America 02110
- IPO Date
- Oct 3, 2011
- CIK
- 0000772129
- Similar Companies
- Business
- GMO SGM Major Markets Fund (GSMFX) is a mutual fund managed by GMO Trust, part of Grantham, Mayo, Van Otterloo & Co. LLC (GMO), that seeks long-term total return through systematic global tactical asset allocation. The fund typically invests in a portfolio of long and short positions across global equity, bond, currency, and commodity markets, primarily utilizing exchange-traded and over-the-counter futures, forward currency contracts, swaps, index options, as well as direct investments in equities and bonds. It targets inefficiencies in major markets via proprietary investment models for asset allocation and market selection, including commodity-related derivatives through a wholly-owned subsidiary. Headquartered in Boston, Massachusetts, at 53 State Street (with operations linked to 40 Rowes Wharf), the fund operates under GMO, a firm founded in 1977 with a contrarian, valuation-driven approach and global offices in locations including London, Tokyo, and Singapore. GMO SGM Major Markets Fund was established with an inception date of September 23, 2020, and focuses on institutional and retail investors seeking alternative exposure to major asset classes worldwide. In a significant operational change, the fund was liquidated as of October 13, 2023, with its final net asset value reported at 24.2700 USD, marking the end of its active operations. Its Legal Entity Identifier (LEI) lapsed on November 3, 2024, reflecting post-liquidation wind-down activities. GMO continues to expand its broader offerings, including new emerging-markets ex-China ETFs in 2025 and the 2020 acquisition of Japanese equity manager Usonian for cobranded strategies.